Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia

被引：16
作者：
Miyashita, Naoyuki [1 ]
Oka, Mikio [1 ]
Kawai, Yasuhiro [2 ]
Yamaguchi, Tetsuya [2 ]
Ouchi, Kazunobu [2 ]
机构：
[1] Kawasaki Med Sch, Atyp Pathogen Study Grp, Dept Resp Med, Kurashiki, Okayama 7010192, Japan
[2] Kawasaki Med Sch, Dept Pediat, Kurashiki, Okayama 7010192, Japan
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2010年 / 36卷 / 04期
关键词：
D O I：
10.1016/j.ijantimicag.2010.06.009
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：384 / 385
页数：3
相关论文
共 50 条
  • [21] RAPID DEFERVESCENCE AFTER DOXYCYCLINE TREATMENT OF MACROLIDE-RESISTANT MYCOPLASMA PNEUMONIAE-ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN
    Lung, David Christopher
    Tong, Eric Kam
    Lam, David Shu Yan
    Que, Tak Lun
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (12) : 1396 - 1399
  • [22] Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia Is There Still a Role for Macrolide Therapy?
    Niederman, Michael S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (11) : 1216 - 1217
  • [23] The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae
    Antonakos, Nikos
    Giamarellos-Bourboulis, Evangelos J.
    Niederman, Michael S.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2025, 38 (02) : 190 - 197
  • [24] The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
    Dai, Fang-fang
    Liu, Feng-qin
    Chen, Xing
    Yang, Juan
    Wang, Ke
    Guo, Chun-yan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 705 - 710
  • [25] Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure
    Cheong, Kai-Ning
    Chiu, Susan S.
    Chan, Betsy Wai-Ka
    To, Kelvin Kai-Wang
    Chan, Eunice Lai-Yin
    Ho, Pak-Leung
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (01) : 127 - 130
  • [26] Efficacy of Azithromycin in the Treatment of Community-acquired Pneumonia, Including Patients with Macrolide-Resistant Streptococcus pneumoniae Infection
    Yanagihara, Katsunori
    Izumikawa, Koichi
    Higa, Futoshi
    Tateyama, Masao
    Tokimatsu, Issei
    Hiramatsu, Kazufumi
    Fujita, Jiro
    Kadota, Jun-ichi
    Kohno, Shigeru
    INTERNAL MEDICINE, 2009, 48 (07) : 527 - 535
  • [27] Macrolide-Resistant Mycoplasma pneumoniae in Adults in Zhejiang, China
    Zhou, Zibo
    Li, Xiangzhi
    Chen, Xiaojian
    Luo, Fangjun
    Pan, Changwang
    Zheng, Xiaoping
    Tana, Feng
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1048 - 1051
  • [28] Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study
    Yin, Yu-Dong
    Wang, Rui
    Zhuo, Chao
    Wang, Hui
    Wang, Ming-Gui
    Xie, Can-Mao
    She, Dan-Yang
    Yuan, Xin
    Wang, Ren-Tao
    Cao, Bin
    Liu, You-Ning
    JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 3774 - 3781
  • [29] Macrolide-resistant Streptococcus pneumoniae in community-acquired pneumonia:: Clinical and microbiological outcomes for patients treated with levofloxacin
    Kahn, JB
    Wiesinger, BA
    Xiang, J
    CLINICAL INFECTIOUS DISEASES, 2004, 38 : S24 - S33
  • [30] Mycoplasma pneumoniae and community-acquired pneumonia
    Dey, AB
    Chaudhry, R
    Kumar, P
    Nisar, N
    Nagarkar, KM
    NATIONAL MEDICAL JOURNAL OF INDIA, 2000, 13 (02) : 66 - 70
12345